We offer an expansive portfolio of defined human recombinant laminin matrices, Biolaminin®, for a variety of applications, such as expansion of human pluripotent stem cells and differentiation and maintenance of different specialised cell types. The biologically relevant cell-matrix interaction leads to improved cell functionality, robust culture systems and safe cells for therapy. BioLamina’s laminin technology has been scientifically validated in many high impact journals.